We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Upgraded Analyzer and Dedicated Microplate Combo Enables Long-Term Studies of Cell Functions

By LabMedica International staff writers
Posted on 09 Jul 2012
The introduction of a dedicated low-evaporation 96-well microplate for use with an upgraded automatic cell analyzer system brings biotechnology researchers a platform for long-term cell-based studies over several days or weeks.

Tecan (Männedorf, Switzerland), the manufacturer of the Infinite 200 PRO multimode reader has updated the instrument’s patent pending Gas Control Module (GCM) to offer simultaneous control of oxygen and carbon dioxide concentrations, providing rigor in environmental control for a wide range of cell biology applications. More...
The original GCM, which was a breakthrough for cell­based experiments, has now been further enhanced to provide increased measurement accuracy and to minimize cross-interference for oxygen measurements. Combined with redesigned, independent gas inlets, this offers precise, independent control of both oxygen and carbon dioxide levels within the reader, with automatic compensation for variations in the atmospheric partial pressure of carbon dioxide via a unique altitude correction function.

To complement and extend the range of the Infinite 200 PRO Thermo Fisher Scientific Inc., (Waltham, MA, USA) has introduced its line of Nunc Edge microplates. Nunc Edge plates incorporate large perimeter evaporation buffer zones that eliminate well-to-well variability while reducing the overall plate evaporation rate to less than 2% after seven days of incubation.

Combining the GCM features of the reader with the unique evaporation moat feature of the Nunc Edge Plate, the researcher is able to maintain precisely the carbon dioxide and oxygen balance inside the reader’s chamber. This prevents an unwanted pH shift that could result in loss in cell viability, proliferation stop, or cell death. The entire microplate can be used without danger of development of the “edge effect” that routinely occurs due to evaporation from the outer 36 wells of a regular 96-well-plate.

Tecan has included Nunc Edge plate specifications in all of its reader software, saving valuable equipment setup time.

Related Links:

Tecan
Thermo Fisher Scientific Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Prefilled Tubes
Prefilled 5.0ml Tubes
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.